Hostname: page-component-89b8bd64d-dvtzq Total loading time: 0 Render date: 2026-05-07T10:40:24.145Z Has data issue: false hasContentIssue false

Impact of airline network on the global importation risk of mpox, 2022

Published online by Cambridge University Press:  21 March 2023

Ryo Kinoshita
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan Kyoto University School of Public Health, Kyoto, Japan
Miho Sassa
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Shogo Otake
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan Department of Pediatrics, Graduate School of Medicine, Kobe University, Hyogo, Japan
Fumi Yoshimatsu
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan
Shoi Shi
Affiliation:
Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Ryo Ueno
Affiliation:
The Australian and New Zealand Intensive Care Research Centre, Melbourne, Australia
Motoi Suzuki
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan
Daisuke Yoneoka*
Affiliation:
National Institute of Infectious Diseases, Tokyo, Japan Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan Tokyo Foundation for Policy Research, Tokyo, Japan
*
Author for correspondence: Daisuke Yoneoka, E-mail: yoneoka@niid.go.jp
Rights & Permissions [Opens in a new window]

Abstract

From 1 January 2022 to 4 September 2022, a total of 53 996 mpox cases were confirmed globally. Cases are predominantly concentrated in Europe and the Americas, while other regions are also continuously observing imported cases. This study aimed to estimate the potential global risk of mpox importation and consider hypothetical scenarios of travel restrictions by varying passenger volumes (PVs) via airline travel network. PV data for the airline network, and the time of first confirmed mpox case for a total of 1680 airports in 176 countries (and territories) were extracted from publicly available data sources. A survival analysis technique in which the hazard function was a function of effective distance was utilised to estimate the importation risk. The arrival time ranged from 9 to 48 days since the first case was identified in the UK on 6 May 2022. The estimated risk of importation showed that regardless of the geographic region, most locations will have an intensified importation risk by 31 December 2022. Travel restrictions scenarios had a minor impact on the global airline importation risk against mpox, highlighting the importance to enhance local capacities for the identification of mpox and to be prepared to carry out contact tracing and isolation.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press
Figure 0

Fig. 1. (a) Entire flight network before travel restrictions (as of 1 December 2019). Colour indicates the passenger volume (PV) in log scale. (b) Flight network from the UK and Heathrow Airport (as of 1 December 2019).

Figure 1

Fig. 2. (a) Estimated risk of importation of mpox as of 5 September 2022. Colour indicates the estimated risk and the size of circles indicates the number of inbound passenger volume of each airport. (b) Predicted risk of importation of mpox as of 31 December 2022.

Figure 2

Fig. 3. (a) Predicted relative risk change under the assumption of H1 as of 31 December 2022. Colour indicates the estimated relative risk change. (b) Predicted relative risk change under the assumption of H2 as of 31 December 2022. (c) Predicted relative risk change under the assumption of H3 as of 31 December 2022.

Figure 3

Table 1. Estimated risk among top and bottom five country/territory in Figures 2 and 3

Supplementary material: Image

Kinoshita et al. supplementary material

Kinoshita et al. supplementary material 1

Download Kinoshita et al. supplementary material(Image)
Image 2.2 MB
Supplementary material: Image

Kinoshita et al. supplementary material

Kinoshita et al. supplementary material 2

Download Kinoshita et al. supplementary material(Image)
Image 43.6 MB